Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Shares, par value $1.00 per share
-
Shares outstanding
-
58,404,497
-
Total 13F shares
-
44,838,936
-
Share change
-
+44,826,336
-
Total reported value
-
$1,117,387,025
-
Price per share
-
$24.92
-
Number of holders
-
63
-
Value change
-
+$1,117,073,033
-
Number of buys
-
62
Institutional Holders of KESTRA MEDICAL TECHNOLOGIES, LTD. - Common Shares, par value $1.00 per share (KMTS) as of Q1 2025
As of 31 Mar 2025,
KESTRA MEDICAL TECHNOLOGIES, LTD. - Common Shares, par value $1.00 per share (KMTS) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,838,936 shares.
The largest 10 holders included
Bain Capital Investors LLC, FMR LLC, Yu Fan, T. Rowe Price Investment Management, Inc., Omega Fund Management, LLC, ALLIANCEBERNSTEIN L.P., Holocene Advisors, LP, CITADEL ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, and BROWN ADVISORY INC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.